AQST Q1 2019 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$13M-46.0% YoY

Gross Profit

$9M72.3% margin

Operating Income

-$13M-103.4% margin

Net Income

-$15M-116.5% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

-24.9%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$68M

Total Liabilities

$74M

Stockholders' Equity

-$6M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$23M	-46.0%
Gross Profit	$9M	$18M	-48.6%
Operating Income	-$13M	$5M	-346.4%
Net Income	-$15M	$4M	-459.3%

Revenue Segments

Manufacture and Supply Revenue

$7M59%

License and Royalty Revenue

$5M41%